TheEdgeResearch
Home / Stocks / PRCT

PROCEPT BioRobotics Corporation (PRCT)

NASDAQ Healthcare Medical - Devices
$16.69 ▼ -4.90%
Market Cap
$950.0M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.87
52-Wk Range
16.665-58.87
CEO
Larry L. Wood
Country
US
Currency
USD

PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across…

Open full interactive analysis & DCF →